The limb girdle muscular dystrophies: Our ever-expanding knowledge

Matthew P. Wicklund, Jerry R. Mendell

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations

Abstract

The limb girdle muscular dystrophies (LGMDs) represent a genetically diverse group of disorders. Currently, chromosomal loci are known for at least 5 autosomal-dominant and 10 autosomal-recessive subgroups. in 13 of these, recognized genes and protein products generate an assortment of phenotypes, some unique and many over-lapping. In some disorders, novel clinical features are sufficiently distinct so as to proffer clues to the diagnosis of a specific LGMD subtype. An armamentarium of laboratory tools is required to confirm specific subtypes of LGMD. These might only be available in neuromuscular centers specializing in this form of dystrophy. Currently, supportive therapy is the predominant means of treatment, but further understanding of unique pathogenic mechanisms holds promise for the future.

Original languageEnglish (US)
Pages (from-to)12-28
Number of pages17
JournalJournal of Clinical Neuromuscular Disease
Volume5
Issue number1
DOIs
StatePublished - Sep 2003
Externally publishedYes

Keywords

  • Calpain
  • Caveolin
  • Dysferlin
  • Fukutin-related protein
  • Lamin A/C
  • Limb girdle
  • Muscular dystrophy myotilin
  • Sarcoglycan
  • TRIM 32
  • Telethonin
  • Titin0

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'The limb girdle muscular dystrophies: Our ever-expanding knowledge'. Together they form a unique fingerprint.

Cite this